Quantum BioPharma signs PPD contract for Phase 2 MS trial
Quantum BioPharma has signed a study start-up agreement with Thermo Fisher’s PPD clinical research unit to implement a Phase 2 trial of Lucid-MS for progressive multiple sclerosis.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.